The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: results from a randomized, double-blind, placebo-controlled, cross-over trial.

Plain-language guide to PMID 18331269 (2008): double-blind randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID: 18331269
Journal: The journal of sexual medicine
Year: 2008
Study type: Randomized Controlled Trial
Authors: Harte CB et al. (2 authors)
DOI: 10.1111/j.1743-6109.2008.00778.x

What This Study Did, in Plain Language

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.

To examine whether isolated nicotine intake acutely affects sexual arousal responses in nonsmoking women.

Why It Was Studied

However, results of limited data investigating this relationship in women are mixed.

No studies have examined the acute effects of tobacco or nicotine on physiological sexual response in women.

Who Took Part

The age groups tagged for this paper are teenagers and adults, women only.

How the Study Was Run

The researchers set it up as a randomized, double-blind, placebo-controlled and crossover study.

The participants were allocated by chance, so the Therapeutic nicotine (patch, non-peptide) group and the comparison group should start out alike.

As a double-blind Therapeutic nicotine (patch, non-peptide) study, the assignments were hidden from both participants and investigators until the end.

The comparison arm used a placebo, so changes seen with Therapeutic nicotine (patch, non-peptide) could be set against what happens without it.

In the crossover set-up each of the participants took both Therapeutic nicotine (patch, non-peptide) and the comparison in turn, acting as their own control.

What Was Measured

Topics PubMed links to this paper include Chewing Gum, Contraceptives, Oral, Hormonal, Heart Rate, Libido, Nicotine, Nicotinic Agonists and Photic Stimulation.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Therapeutic nicotine (patch, non-peptide).

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2008 (The journal of sexual medicine), a journal based in Netherlands.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Therapeutic nicotine (patch, non-peptide) in the library

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.